ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

November 15, 2002

Barbara Rimer and Owen Witte To Be Named Members Of the President’s Cancer Panel

December 9, 2011

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

Frelick Heads ACCC, Kerman Names President-Elect

March 14, 1980

In Brief: Maguire Wants Five Environmental Experts In Addition To Those On The Board

February 16, 1979

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002